5 Results for "

CPA4

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "CPA4" in MCE Product Catalog:

  • Recombinant Proteins Recommended:
Cat. No.: HY-RS03083
Research Areas:  

Others

CPA4 Human Pre-designed siRNA Set A contains three designed siRNAs for CPA4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS19589
Research Areas:  

Others

Cpa4 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Cpa4 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS26086
Research Areas:  

Others

Cpa4 Rat Pre-designed siRNA Set A contains three designed siRNAs for Cpa4 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-P70078
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: rMuCarboxypeptidase A4/CPA4, His; CPA4; Carboxypeptidase A4
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-184654
CAS No.: 2169267-60-9
MR-39 is a FPR2 agonist (EC50 = 3.9 μM). MR-39 activates FPR2 to promote neuroinflammation resolution (downregulates IL-1β and TNF-α, modulates NF-κB), upregulates synaptic proteins (synaptic proteins) and improves dendritic spine morphology. MR-39 inhibits MAPK/ERK and AKT phosphorylation in glioblastoma, induces S-phase arrest, and suppresses migration, angiogenesis, and hypoxic adaptation. MR-39 reduces Aβ plaque burden via inhibiting MyD88/NF-κB and NLRP3 inflammasome. MR-39 can be used for research on autism spectrum disorder, Alzheimer's disease, and glioblastoma [4].
loading...
    loading...